https://www.prnewswire.com/news-releases/quralis-announces-topline-data-from-its-phase-1-clinical-trial-of-qrl-101-evaluating-biomarkers-of-als-and-epilepsy-in-healthy-volunteers-302399085.html
QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of...
/PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines...
https://www.businesswire.com/news/home/20251202434479/en/QurAlis-to-Present-Data-From-its-Phase-1-Clinical-Trial-of-QRL-101-a-Potential-Best-in-Class-Selective-Kv7.27.3-Ion-Channel-Opener-at-American-Epilepsy-Society-2025-Annual-Meeting
QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class...
QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alt...
https://www.fiercebiotech.com/keyword/quralis
QurAlis | Fierce Biotech
quralisfiercebiotech
https://www.biospace.com/quralis-expands-leadership-team-with-doug-williamson-m-d-as-chief-medical-officer-and-jason-brown-mba-as-chief-financial-officer-and-appoints-shafique-virani-m-d-to-board-of-directors
QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason...
Jun 12, 2024 - QurAlis Corporation announced that it has appointed Douglas Williamson, M.D., as chief medical officer and Jason Brown, MBA, as chief financial officer.
https://www.quralis.com/
Neuro Pioneers on a Quest to Cure - QurAlis
Dec 10, 2025 - At QurAlis, we consider ourselves “neuro pioneers” because we are driven to explore the deepest aspects of human neurology in order to find the treatments
on a questneuropioneerscurequralis